Valeant appoints new board member

pharmafield logo - pharma news


Valeant Pharmaceuticals International has appointed Ronald Farmer to its Board of Directors.

J. Michael Pearson, Chairman and CEO of Valeant, stated that it was a “privilege” to welcome Mr Farmer’s “unparalleled intellect and superior business judgment” to the Board.

Mr Farmer currently works as Managing Director of Mosaic Capital Partners in Toronto, Canada. He is also a Director at Integran Technologies, PowerMetal Technologies and Boatracs Inc.

Valeant Pharmaceuticals International is a global pharmaceutical company that develops, manufactures and markets pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.